Franco-Indian
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- GR8 capsule, hard 20 mg+10 mg
- GR8 OD capsule, hard 40 mg+30 mg
- A10 - Antidiabéticos
- CLAZ M OD prolonged-release tablet 500 mg+30 mg
- CLAZ M OD prolonged-release tablet 500 mg+60 mg
- CLAZ OD capsule, hard 30 mg
- CLAZ OD capsule, hard 60 mg
- GLEAM tablet 1 mg
- GLEAM tablet 2 mg
- GLIDE tablet 5 mg
- GLIMET DS tablet 500 mg+5 mg
- GLIMET tablet 250 mg+2.5 mg
- GLYCIPHAGE G tablet 500 mg+1 mg
- GLYCIPHAGE G tablet 500 mg+2 mg
- GLYCIPHAGE P tablet 500 mg+15 mg
- GLYCIPHAGE P tablet 500 mg+30 mg
- GLYCIPHAGE PG1 tablet 500 mg+15 mg+1 mg
- GLYCIPHAGE PG2 tablet 500 mg+15 mg+2 mg
- GLYCIPHAGE SR prolonged-release tablet 1 000 mg
- GLYCIPHAGE SR prolonged-release tablet 500 mg
- GLYCIPHAGE tablet 250 mg
- GLYCIPHAGE tablet 500 mg
- GLYCIPHAGE tablet 850 mg
- A11 - Vitaminas
- BEETRION tablet
- BENALGIS tablet 100 mg
- BENALGIS tablet 75 mg
- BENEURON FORTE tablet
- DIAVIT capsule, soft
- DIAVIT PLUS capsule, soft
- NATIVE C capsule, soft 200 mg+150 mg
- NATIVE C capsule, soft 400 mg+150 mg
- B03 - Preparados antianémicos
- DEXORANGE capsule, soft 160 mg+7.5 µg+0.5 mg+20.61 mg
- DEXORANGE PAED syrup 50 mg/5 ml+2.5 µg/5 ml+0.2 mg/5 ml
- DEXORANGE syrup 160 mg/5 ml+7.5 µg/5 ml+0.5 mg/5 ml
- C01 - Terapia cardíaca
- NATCARDINE tablet 100 mg
- C10 - Agentes modificadores de los lípidos
- ATHEART EZ film-coated tablet 10 mg+10 mg
- FINATE capsule, hard 200 mg
- N02 - Analgésicos
- GRILINCTUS syrup
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- GRILINCTUS BM P syrup 1.5 mg/5 ml+4 mg/5 ml
- GRILINCTUS BM syrup 2.5 mg/5 ml+8 mg/5 ml
- GRILINCTUS BM tablet 2.5 mg+8 mg